Controversy continues over the human papillomavirus (HPV) vaccine used to prevent cervical cancer in women. Reports suggest India’s health ministry will not include it under the country’s universal immunisation programme (UIP). Estimates suggest 1 in 53 women in India will develop cervical cancer in their lifetime. It is believed 423.2 million … [Read more...] about Controversy continues over HPV vaccine and cervical cancer
President of the Philippines Rodrigo Duterte is keen to capitalise on India’s generic medicines industry. Biateral talks occurred last month between Duterte and Prime Minister Narendra Modi at the Philippine International Convention Centre in Pasay City. During the talks, Duterte noted the potential of India’s pharmaceutical industry to expand … [Read more...] about India to become the pharmacy of the Philippines?
On November 8, 2014, 140 women underwent surgery in two state-run sterilisation camps in Chhattisgarh. Five days later, thirteen of them had died. The tragedy grabbed global headlines. Three years later, it remains an open wound in India. At the time, it seemed as if there was one, easy-to-identify cause that could be addressed through changed … [Read more...] about Chhattisgarh sterilisation camp deaths: Three years on
Hyderabad’s pharma boom is having a devastating effect on the environment. Five major pharmaceutical companies have been charged with making water and the atmosphere toxic. The Telangana State Pollution Control Board (TSPCB) warn that the state capital’s emerging pharmaceutical industry faces ‘stringent action’ because of pollution from pharma … [Read more...] about A climate of pollution in Hyderabad: Pharma to blame?
Drugmakers could face new marketing restrictions in India, should new rules come into force. A set of marketing rules would limit the amount drugmakers can spend on gifts and trips offered to doctors and pharmacists to Rs 1,000 (US$15) per gift. The proposals propose stringent penalties. Violating the rules would result in a marketing … [Read more...] about Marketing to doctors: Pharma faces crackdown
India's long-awaited and divisive Goods and Services Tax (GST) will soon take effect. What effect will it have on healthcare? The GST has effectively more than thirty years in the making. A large-scale stab at tax reform, it seeks to impose a levy on all goods and services across India at the national level. The GST has been ratified by all but … [Read more...] about India’s Goods and Services Tax (GST): What does it mean for pharma?
This has been reproduced, with permission, from The News Minute. Full credit goes to the author Ramanathan S. (@madrassi). The original article can be accessed here Not very far from the Serpentine Bar at the Palace of Nations in Geneva, the United Nations HQ, where both lobbyists of the private sector and non-state actors are competing to … [Read more...] about What else we’re reading: India is fighting at the WHO to make medicines cheaper, but drug quality is the real problem
"Bucking the trend" India’s drug market is starting to show signs of improvement after a rough few months, with everything from demonetisation to Donald Trump taking its toll. However, the future remains very much unclear. Demonetisation The Indian pharmaceutical market (IPM) is “bucking the trend of a sequential decline” according to … [Read more...] about Bucking the trend: Is India’s drug market back on the up?
Ties between one of India’s largest immunization programs and the Gates Foundation have been cut, media reports suggest. However, the Health Ministry dismisses such claims as “misleading.” "Shut the gate" on Gates The Economic Times reports that the Modi government has “shut the gate” on the Bill & Melinda Gates Foundation as far as the … [Read more...] about Gates Foundation and India: ties cut or fake news at play?
The Modi government’s Union Budget for the fiscal year 2017-18 was presented by Finance Minister Arun Jaitley on February 1. Jaitley announced a number of steps to address the plentiful problems facing India’s healthcare system. However, critics said that there were only paltry increases in funding following a year of severe cuts - a “nominal” … [Read more...] about Health budget: Making progress or playing it safe?